RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice

Volume: 2, Issue: 10, Pages: 1113 - 1125
Published: Sep 28, 2020
Abstract
Obesity is a major public health burden worldwide and is characterized by chronic low-grade inflammation driven by the cooperation of the innate immune system and dysregulated metabolism in adipose tissue and other metabolic organs. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) is a central regulator of inflammatory cell function that coordinates inflammation, apoptosis and necroptosis in response to inflammatory stimuli. Here...
Paper Details
Title
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice
Published Date
Sep 28, 2020
Volume
2
Issue
10
Pages
1113 - 1125
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.